AESKULISAAESKULISA® Thrombosis Test Kits
FDA cleared Products


AESKU.DIAGNOSTICS offers the most comprehensive panel of anti-phospholipid tests. Two major serological parameters for diagnosis are well established: antibodies against the native human β2-glycoprotein I and against the highly purified cardiolipin.

However, there is increasing evidence from a number of studies that testing a profile of various phospholipids increases both sensitivity and specificity of the laboratory diagnosis.

 

Reference
Description
Kit Config
Antibodies
Quant.
Qual.
Cut Off
Range
Standard

β2 Glyco-A (FDA cleared)
Single-A
IgA
Quant.
Qual.
15
0-300 U/ml
-
β2-Glyco-GM (FDA cleared)
Single-GM
IgG, IgM
Quant.
Qual.
15
0-300 U/ml
Sapporo
β2 Glyco-Check
(FDA cleared)
Single-Check
IgA, IgG, IgM
Quant.
Qual.
20
0-300 U/ml
-
Cardiolipin-Check
(FDA cleared)
Single-Check
IgA, IgG, IgM
Quant.
Qual.
20
0-300 U/ml
-
Cardiolipin-A (FDA cleared)
Single-A
IgA
Quant.
Qual.
15
0-300 U/ml
Harris
Cardiolipin-GM (FDA cleared)
Single-GM
IgG, IgM
Quant.
Qual.
15
0-300 U/ml
Harris
Sapporo